ClarIDHy: A Phase 3, multicenter, randomized, double-blind of orally administered AG-120 for patients with advanced cholangiocarcinoma and an IDH1 gene mutation.

Study Name ClarIDHy: A Phase 3, multicenter, randomized (people are allocated by chance to receive one of clinical interventions) double-blind (neither the participant nor the investigator know who is receiving AG-120 or the placebo) of orally administered AG-120 for patients with advanced cholangiocarcinoma and an IDH1 gene mutation. ClinicalTrials.gov Identifier (if applicable) NCT02989857 Study Center Institution Name Agios (study sponsor) Institution Address 88 Sidney Street City Cambridge State Massachusetts Zip Code 02139 Phone (617) 649-8600 Website http://www.ClarIDHy.com List additional Institutions (include address, phone number, and website) Fox Chase Cancer Center, Philadelphia, PA, United States MD Anderson Cancer Center, Houston, TX, United States Memorial Sloan Kettering Cancer Center, New York, NY, United States Sarah Cannon Cancer Center, Nashville, TN, United States Study Contacts Principal Investigator Agios Medical Affairs P.I. Phone (844) 633-2332 P.I. Email medinfo@agios.com List additional Principal Investigators (include phone number and email) To find a study near you...

A Phase 2 Open-Label Study in Patients with Cholangiocarcinoma

Study Name   A Phase 2 Open-Label Study in Patients with Cholangiocarcinoma ClinicalTrials.gov Identifier (if applicable)   NCT02924376 Study Center Institution Name   Incyte Corporation Institution Address   1801 Augustine Cut-Off City   Wilmington State   Delaware Zip Code   19803 Phone   (855) 463-3463 Study Contacts Principal Investigator   A lead investigator has not been identified yet (TBD) P.I. Phone   (855) 463-3463 P.I. Email   TBD@XYZ.com List additional Principal Investigators (include phone number and email)   Please refer to the Clinical Trials.gov listing and contact the Incyte Help Line at 855-463-3463 for a research center near you. Study Coordinator   TBD Study Coordinator Phone   (855) 463-3463 Study Coordinator Email   TBD@XYZ.com List additional Study Coordinators (include phone number and email)   Please refer to the Clinical Trials.gov listing and contact the Incyte Help Line at 855-463-3463 for a research center near you. OVERVIEW – in layman’s...

Immunotherapy

Our friends at Memorial Sloan Kettering have put together an excellent animation explaining...

Tanios Bekaii-Saab, MD, FACP

Following completing his undergraduate studies at McGill University in Montreal, Dr. Bekaii-Saab earned his medical degree from the American University of Beirut in Lebanon. This was followed by a residency in internal medicine at Indiana University Medical Center in Indianapolis, Indiana. He then completed fellowships in clinical pharmacology and experimental therapeutics and hematology/oncology at Tufts University/New England Medical Center in Boston, Massachusetts. Dr. Bekaii-Saab joined the faculty at the Mayo Clinic in May 2016 as Co-Leader of the Enterprise wide Gastrointestinal Cancer Program at the Mayo Clinic Cancer Center and Professor at the Mayo Clinic College of Medicine and Science. He is also a Senior Associate Consultant, Division of Hematology and Oncology in Mayo Clinic Arizona. He was previously at the Ohio State University – Arthur G. James Cancer Hospital and Solove Research Institute as a tenured Professor of Medicine and Pharmacy, and Section Chief for the Gastrointestinal Cancer...

CCF meets with CASCAP and The Cholangiocarcinoma Foundation of Thailand

From our friends at CASCAP … CASCAP and together with The Cholangiocarcinoma Foundation of Thailand hosted a meeting with Prof. John Bridgewater University of London, Stacie Lindsey , President, Cholangiocarcinoma Foundation USA, Prof. Milind Javle M.D., Tenure Track, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX . Vice Chair of the Cholangiocarcinoma Foundation USA, Asst. Prof. Dr. Yun Shin Chun M.D., Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. Dr. Mitesh J. Borad, M.D. Mayo Clinic, Department of Oncology, Phoenix, Arizona, Sean Tuberville Board member, Cholangiocarcinoma Foundation USA., and Patty Maxin, Patient Advocate, Cholangiocarcinoma Foundation USA.   This first meeting with our US counterparts will greatly help to further establish and grow a very important global alliance to combat CCA. We greatly appreciate our friends from US and...

Pin It on Pinterest